Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marko Noc

Showing results (101-110 of 134) with videos related to

Pageof 14
Sort By:
Journal of Thrombosis and Thrombolysis|March 10, 2010
Gender-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperationGiuseppe De Luca, C Michael Gibson, Mariann Gyöngyösi, et al.
Journal of Thrombosis and Thrombolysis|November 19, 2009
Impact of distal embolization on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperationGiuseppe De Luca, C Michael Gibson, Francesco Bellandi, et al.
Atherosclerosis|May 12, 2009
Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb-IIIa inhibitorsGiuseppe De Luca, C Michael Gibson, Francesco Bellandi, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 23, 2013
Impact of time-to-treatment on myocardial perfusion after primary percutaneous coronary intervention with Gp IIb-IIIa inhibitorsGiuseppe De Luca, Michael C Gibson, Arnoud W J Van't Hof, et al.
The American Journal of Cardiology|August 6, 2013
Impact of hypertension on distal embolization, myocardial perfusion, and mortality in patients with ST segment elevation myocardial infarction undergoing primary angioplastyGiuseppe De Luca, Arnoud W J van't Hof, Kurt Huber, et al.
The Journal of Invasive Cardiology|July 12, 2012
Impact of preprocedural TIMI flow on myocardial perfusion, distal embolization and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb/IIIa inhibitorsMauro Maioli, Uwe Zeymer, Arnoud W J van 't Hof, et al.
Journal of Thrombosis and Thrombolysis|November 26, 2008
Benefits of pharmacological facilitation with glycoprotein IIb-IIIa inhibitors in diabetic patients undergoing primary angioplasty for STEMI. A subanalysis of the EGYPT cooperationGiuseppe De Luca, C Michael Gibson, Francesco Bellandi, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 17, 2021
Clopidogrel vs. prasugrel vs. ticagrelor in patients with acute myocardial infarction complicated by cardiogenic shock: a pooled IABP-SHOCK II and CULPRIT-SHOCK trial sub-analysisMartin Orban, Jan Kleeberger, Taoufik Ouarrak, et al.
Archives of Cardiovascular Diseases|April 16, 2013
Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitorsGiuseppe De Luca, Michael Gibson, Donald Cutlip, et al.
Heart and Vessels|March 16, 2013
Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitorsGiuseppe De Luca, Arnoud W J van't Hof, Kurt Huber, et al.
Pageof 14

Showing results (101-110 of 134) with videos related to

Sort By:
Pageof 14
Journal of Thrombosis and Thrombolysis|March 10, 2010
Gender-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperationGiuseppe De Luca, C Michael Gibson, Mariann Gyöngyösi, et al.
Journal of Thrombosis and Thrombolysis|November 19, 2009
Impact of distal embolization on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors: insights from the EGYPT cooperationGiuseppe De Luca, C Michael Gibson, Francesco Bellandi, et al.
Atherosclerosis|May 12, 2009
Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb-IIIa inhibitorsGiuseppe De Luca, C Michael Gibson, Francesco Bellandi, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 23, 2013
Impact of time-to-treatment on myocardial perfusion after primary percutaneous coronary intervention with Gp IIb-IIIa inhibitorsGiuseppe De Luca, Michael C Gibson, Arnoud W J Van't Hof, et al.
The American Journal of Cardiology|August 6, 2013
Impact of hypertension on distal embolization, myocardial perfusion, and mortality in patients with ST segment elevation myocardial infarction undergoing primary angioplastyGiuseppe De Luca, Arnoud W J van't Hof, Kurt Huber, et al.
The Journal of Invasive Cardiology|July 12, 2012
Impact of preprocedural TIMI flow on myocardial perfusion, distal embolization and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb/IIIa inhibitorsMauro Maioli, Uwe Zeymer, Arnoud W J van 't Hof, et al.
Journal of Thrombosis and Thrombolysis|November 26, 2008
Benefits of pharmacological facilitation with glycoprotein IIb-IIIa inhibitors in diabetic patients undergoing primary angioplasty for STEMI. A subanalysis of the EGYPT cooperationGiuseppe De Luca, C Michael Gibson, Francesco Bellandi, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 17, 2021
Clopidogrel vs. prasugrel vs. ticagrelor in patients with acute myocardial infarction complicated by cardiogenic shock: a pooled IABP-SHOCK II and CULPRIT-SHOCK trial sub-analysisMartin Orban, Jan Kleeberger, Taoufik Ouarrak, et al.
Archives of Cardiovascular Diseases|April 16, 2013
Impact of multivessel disease on myocardial perfusion and survival among patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitorsGiuseppe De Luca, Michael Gibson, Donald Cutlip, et al.
Heart and Vessels|March 16, 2013
Impact of advanced age on myocardial perfusion, distal embolization, and mortality patients with ST-segment elevation myocardial infarction treated by primary angioplasty and glycoprotein IIb-IIIa inhibitorsGiuseppe De Luca, Arnoud W J van't Hof, Kurt Huber, et al.
Pageof 14